DNTH — Dianthus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Dianthus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	146	149	177	112	174
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.478
Prepaid Expenses
Total Current Assets	150	152	181	116	177
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.89	8.31	7.46	29.3	0.8
Other Long Term Assets
Total Assets	162	162	190	147	179
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.1	11.4	10.9	14.5	9.63
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	20.3	17.7	17.3	40.7	10.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	141	144	173	106	169
Total Liabilities & Shareholders' Equity	162	162	190	147	179
Total Common Shares Outstanding